Literature DB >> 16806259

The effect of myosin regulatory light chain phosphorylation on the frequency-dependent regulation of cardiac function.

Fernando A L Dias1, Lori A Walker, Grace M Arteaga, John S Walker, Kalpana Vijayan, James R Peña, Yunbo Ke, Rosalvo T H Fogaca, Atsushi Sanbe, Jeffrey Robbins, Beata M Wolska.   

Abstract

Although it has been suggested that in cardiac muscle the phosphorylation level of myosin regulatory light chain (RLC) correlates with frequency of stimulation, its significance in the modulation of the force-frequency and pressure-frequency relationships remains unclear. We examined the role of RLC phosphorylation on the force-frequency relation (papillary muscles), the pressure-frequency relation (Langendorff perfused hearts) and shortening-frequency relation (isolated cardiac myocytes) in nontransgenic (NTG) and transgenic mouse hearts expressing a nonphosphorylatable RLC protein (RLC(P-)). At 22 degrees C, NTG and RLC(P-) muscles showed a negative force-frequency relation. At 32 degrees C, at frequencies above 1 Hz, both groups showed a flat force-frequency relation. There was a small increase in RLC phosphorylation in NTG muscles when the frequency of stimulation was increased from 0.2 Hz to 4.0 Hz. However, the level of RLC phosphorylation in these isolated muscles was significantly lower compared to samples taken from NTG intact hearts. In perfused hearts, there was no difference in the slope of pressure-frequency relationship between groups, but the RLC(P-) group consistently developed a reduced systolic pressure and demonstrated a decreased contractility. There was no difference in the level of RLC phosphorylation in hearts paced at 300 and 600 bpm. In RLC(P-) hearts, the level of TnI phosphorylation was reduced compared to NTG. There was no change in the expression of PLB between groups, but expression of SERCA2 was increased in hearts from RLC(P-) compared to NTG. In isolated cardiac myocytes, there was no change in shortening-frequency relationship between groups. Moreover, there was no change in Ca(2+) transient parameters in cells from NTG and RLC(P-) hearts. Our data demonstrate that in cardiac muscle RLC phosphorylation is not an essential determinant of force- and pressure-frequency relations but the absence of RLC phosphorylation decreases contractility in force/pressure developing preparations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806259     DOI: 10.1016/j.yjmcc.2006.05.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

1.  Phosphorylation of myosin regulatory light chain has minimal effect on kinetics and distribution of orientations of cross bridges of rabbit skeletal muscle.

Authors:  Divya Duggal; Janhavi Nagwekar; Ryan Rich; Krishna Midde; Rafal Fudala; Ignacy Gryczynski; Julian Borejdo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-11-27       Impact factor: 3.619

2.  Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.

Authors:  Katherine A Sheehan; Grace M Arteaga; Aaron C Hinken; Fernando A Dias; Cibele Ribeiro; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

3.  Cardiac myosin is a substrate for zipper-interacting protein kinase (ZIPK).

Authors:  Audrey N Chang; Guohua Chen; Robert D Gerard; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

4.  A new state of cardiac myosin with very slow ATP turnover: a potential cardioprotective mechanism in the heart.

Authors:  Pleuni Hooijman; Melanie A Stewart; Roger Cooke
Journal:  Biophys J       Date:  2011-04-20       Impact factor: 4.033

Review 5.  Signaling to myosin regulatory light chain in sarcomeres.

Authors:  Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

6.  Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo.

Authors:  Audrey N Chang; Pavan K Battiprolu; Patrick M Cowley; Guohua Chen; Robert D Gerard; Jose R Pinto; Joseph A Hill; Anthony J Baker; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2015-03-02       Impact factor: 5.157

7.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

8.  Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.

Authors:  Regis R Lamberts; Nazha Hamdani; Tenoedj W Soekhoe; Nicky M Boontje; Ruud Zaremba; Lori A Walker; Pieter P de Tombe; Jolanda van der Velden; Ger J M Stienen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

9.  Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction.

Authors:  Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

10.  Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.

Authors:  W Glenn L Kerrick; Katarzyna Kazmierczak; Yuanyuan Xu; Yingcai Wang; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2008-11-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.